Bill & Melinda Gates Foundation

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed November 14, 2024), Bill & Melinda Gates Foundation reported 5 stock positions worth $40.2 million. Its top holding was Vir Biotechnology (VIR) at 34.5% of the portfolio, followed by Biontech SE-ADR (BNTX, 29.7%) and Exscientia (EXAI, 20.2%). Compared with Q1 2024, it sold out of 3. The biggest sale was an exit from Immunocore Holdings PLC-ADR (IMCR).

Most Recent 13F
Q3 2024
Location
SEATTLE, WA
CIK
0001663801
Portfolio Value
$40.2M (Q2 2024)
SEC Filing
0000898432-24-000921 ↗ filed Nov 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M$100.0M Q1 2024: $84.1M Q1 2024 Q2 2024: $40.2M $40.2M Q2 2024 Q3 2024: $43.5M Q3 2024

Holdings 5 stocks · $40.2M
VIR Vir Biotechnology Inc. 34.50% 1,559,142 $13.9M No change
BNTX Biontech SE-ADR 29.71% 148,674 $11.9M No change
EXAI Exscientia Ltd. 20.17% 1,590,909 $8.1M No change
CVAC Curevac NV 13.51% 1,597,637 $5.4M No change
BFLY Butterfly Network Inc. 2.11% 1,011,003 $849K No change

Portfolio Sells Q1 2024 → Q2 2024
IMCR Immunocore Holdings PLC-ADR Sold out 0.00% −44.58
LMDXF Lumiradx Ltd. Sold out 0.00% −0.17
BCEL Atreca Inc. Class A Sold out 0.00% −0.09

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q3 2024 5$43.5MBNTX, VIR, EXAI, CVAC, BFLY
Q2 2024Amended 5$40.2MVIR, BNTX, EXAI, CVAC, BFLY
Q1 2024 8$84.1MIMCR, VIR, BNTX, EXAI, CVAC